TriconalAlternative Names: Anti-CMV MAb
Latest Information Update: 13 Mar 1995
At a glance
- Originator Unknown
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cytomegalovirus infections
Most Recent Events
- 13 Mar 1995 No-Development-Reported for Cytomegalovirus infections in USA (Unknown route)